NASDAQ:VNDA News 31 December 2025

Healthcare stocks today: FDA decisions jolt biotechs as Wall Street shuts for New Year

Vanda Pharmaceuticals jumped 25% and Axsome rose 23% Wednesday after positive FDA decisions, while Corcept dropped 50% on a regulatory setback. The Health Care Select Sector SPDR Fund (XLV) slipped 0.6% as the S&P 500 fell 0.73%. U.S. markets were closed Thursday for New Year’s Day. Traders now await January macro data and managed-care earnings.

1 January 2026

NASDAQ:AXSM·NASDAQ:CORT·NASDAQ:VNDA

Nasdaq ends 2025 on a down note; markets closed today as jobs report, CPI loom

The Nasdaq Composite dropped 0.8% Wednesday to close 2025 at 23,241.99, while the S&P 500 lost 0.7% and the Dow fell 0.6%. U.S. markets are closed Thursday for New Year’s Day. Investors await the Jan. 9 jobs report, Jan. 13 inflation data, and the start of bank earnings for direction. Trading volume was below average, with tech and energy shares leading declines.

1 January 2026

Nasdaq·NASDAQ:MSFT·NASDAQ:VNDA·NYSE:EQT·Stock Market

Vanda (VNDA) stock jumps 28% after FDA approves Nereus motion-sickness drug

Vanda Pharmaceuticals shares rose 28.1% to $9.01 after the FDA approved Nereus to prevent motion-induced vomiting. Late-stage trials showed vomiting rates of 10%–20% on Nereus versus 38%–44% on placebo. Vanda plans to launch the drug in the coming months, with investors watching pricing and rollout against established over-the-counter competitors.

31 December 2025

NASDAQ:VNDA·Pharmaceuticals

S&P 500 edges down in thin year-end trade as jobless claims fall; Nike, Vanda jump

The Dow fell 114.33 points to 48,252.73, the S&P 500 lost 16.62 to 6,879.62, and the Nasdaq slipped 51.05 to 23,368.03 in thin year-end trading. U.S. jobless claims dropped to 199,000, sending Treasury yields higher. Nike gained after CEO Elliott Hill bought shares. Vanda Pharmaceuticals surged on FDA approval for its motion sickness drug.

31 December 2025

NASDAQ:VNDA·NYSE:NKE·Stock Market

Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades

Vanda Pharmaceuticals shares rose about 18% in premarket trading after the FDA approved its motion-sickness drug Nereus (tradipitant). The company plans to launch the oral treatment in the coming months. The approval followed late-stage trials involving 681 patients. Shares closed at $7.03 Tuesday and were indicated around $8.30 early Wednesday.

31 December 2025

Healthcare News·NASDAQ:VNDA·Pharmaceuticals·Stock Market

GE Aerospace stock price jumps to $321 as dividend rises; what traders watch next week

7 February 2026

GE Aerospace shares closed up 4.78% at $321 Friday after the company raised its quarterly dividend 31% to 47 cents a share. Trading volume reached 5.7 million, above the 50-day average. The stock ended the week 3.54% below its 52-week high. The new dividend is payable April 27 to shareholders of record as of March 9.

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

7 February 2026

Coca-Cola will discontinue its frozen products, including the Minute Maid frozen line, in the U.S. and Canada in Q1 2026. Shares closed Friday up 0.66% at $79.03 ahead of Tuesday’s quarterly results. CEO James Quincey sold 337,824 shares on Feb. 3 for about $26 million under a pre-arranged plan. Options pricing suggests a possible 3% move after earnings.

Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

7 February 2026

Cisco shares closed up 3% at $84.82 Friday after a volatile week for tech stocks. The company will report quarterly results Feb. 11, with analysts expecting EPS of $1.02 on $15.12 billion revenue. U.S. jobs and inflation data, delayed by the federal shutdown, are also due next week. About 23.9 million Cisco shares traded Friday.

Alibaba stock price (BABA) back in focus after Qwen giveaway strains app — what to watch next week

7 February 2026

Alibaba’s U.S.-listed shares closed up 3% at $162.51 Friday after a Qwen app giveaway in China triggered a surge in downloads and service disruptions. Qwen’s free bubble tea offer drove over 10 million orders in nine hours, pushing the app to the top of China’s App Store. Traders await Alibaba’s Feb. 19 earnings and China’s Spring Festival holiday.

NASDAQ:VNDA News 31 December 2025 - 1 January 2026

Healthcare stocks today: FDA decisions jolt biotechs as Wall Street shuts for New Year

Nasdaq ends 2025 on a down note; markets closed today as jobs report, CPI loom

Vanda (VNDA) stock jumps 28% after FDA approves Nereus motion-sickness drug

S&P 500 edges down in thin year-end trade as jobless claims fall; Nike, Vanda jump

Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades

Stock Market Today

GE Aerospace stock price jumps to $321 as dividend rises; what traders watch next week

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

Alibaba stock price (BABA) back in focus after Qwen giveaway strains app — what to watch next week